On October 29, intellectual property leaders in the domestic pharmaceutical industry gathered in Lianyungang to attend the fifth Guozhi Pharmaceutical High-end IP Salon and discuss the review and judgment standards for patents in pharmaceutical fields. Lv Aifeng, president of the Group, and Zhang Chunlin, vice president of the Group, participated in the event. This event was sponsored by the Patent Office of National Intellectual Property Administration, PRC and organized by Hansoh Pharma and Guozhi Patent with the support of the Jiangsu provincial branch and Lianyungang municipal branch of the CNIPA. 

Experts in domestic intellectual property community were invited to the event. Mr. Lv Aifeng, president of the Group, delivered a welcome speech on behalf of Hansoh Pharma, expressing how Hansoh Pharma looked forward to exchanging intellectual property work experiences with the experts, so as to promote the healthy development of China’s pharmaceutical industry. The judgment and review experts from all levels of authorities and agencies shared their insights on domestic and overseas pharmaceutical patent granting and recognition standards. They had a lively discussion with the intellectual property officers from Hansoh Pharma and other pharmaceutical enterprises through in a round-table discussion.

This event focused on the hot topics concerning intellectual property in pharmaceutical fields, and paved the way for the attendees to solve difficulties in intellectual property work at the enterprise level. Such events play an active role in improving the intellectual property management level of the pharmaceutical enterprises.